Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment

Sleep

Volumn 36, Issue 12, 2013, Pages 1831-1837

  Català, Raquel ^a,b   Cabré, Anna ^b,c   Hernández Flix, Salvador ^a,b   Ferré, Raimón ^b,c   Sangenís, Sandra ^a,b   Plana, Núria ^b,c   Texidó, Anna ^a,b   Masana, Lluís ^b,c  

^a Respiratory Department   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adipocyte fatty acid binding protein; Continuous positive airway pressure; Epidermal fatty acid binding protein; Obstructive sleep apnea; Therapy

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 5; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING;

ADIPOCYTE FATTY ACID-BINDING PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; EPIDERMAL FATTY ACID-BINDING PROTEIN; OBSTRUCTIVE SLEEP APNEA; THERAPY;

ADULT; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-SECTIONAL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 84889060166     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3210     Document Type: Article

References (33)

1. Durán J, Esnaola S, Ramón R, Iztueta A. Obstructive sleep apneahypopnea andrelated clinical features in a population-based sample subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001;163:685-9.
2. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
3. Siccoli MM, Pepperell JC, Kohler M, Craig Se, Davies RJ, Stradling Jr. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008;31:1551-8.
4. Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006;27:121-7.
5. Dorkova Z, Petrascova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008;134:686-92.
6. Scheja L, Makowski L, Uysal KT, et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 1999;48:1987-94.
7. Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 1999;40:967-72.
8. Fu Y, Luo N, Lopes-Virella MF, Garvey WT. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 2002;165:259-69.
9. Furuhashi M, Ishimura S, Ota H, Miura T. Lipid chaperones and metabolic inflammation. Int J Inflam 2011;2011:642612.
10. Cabré A, Lázaro I, Girona J, et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007;195:150-8.
11. Tso AW, Xu A, Sham PC, et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007;30:2667-72.
12. Xu A, Tso AW, Cheung BM, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007;115:1537-43.
13. Cabré A, Babio N, Lázaro I, et al. FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 2012;222:229-34.
14. von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 2012;32:2327-35
15. Miyoshi T, Onoue G, Hirohata A, et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 2010;211:164-9.
16. Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012;11:72.
17. Lam DC, Xu A, Lam KS, et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J 2009;33:346-51.
18. Balc MM, Arslan U, Frat H, et al. Serum levels of adipocyte fatty Acidbinding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome. J Invest Med 2012;60:1020-6.
19. Sovova E, Hobzova M, Stejskal D, Sova M, Kolek V, Zapletalova J. Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012;156:58-62.
20. Bhushan B, Khalyfa A, Spruyt K, et al. Fatty-acid banding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med 2011;12:666-71.
21. Yeung DCY, Wang Y, Xu A, et al. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardiometabolic risk factors and carotid atherosclerosis. Eur Heart J 2008;29:2156-63.
22. Hong J, Gu W, Zhang Y, et al. Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults. Atherosclerosis 2011;217:194-200.
23. Ghelfi E, Karaaslan C, Berkelhamer S, Akar S, Kozakewich H, Cataltepe S. Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2011;45:550-6.
24. Chiner E, Arriero JM, Signes-Costa J, Marco J, Fuentes I. Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome. Arch Bronconeumol 1999;35:422-7.
25. Vlachos IS, Hatziioannou A, Perelas A, Perrea DN. Sonographic assessment of regional adiposity. AJR Am J Roentgenol 2007;189:1545-53.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
27. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation and much more. Am J Respir Crit Care Med 2008;177:369-75.
28. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-7.
29. Fisher RM, Eriksson P, Hoffstedt J, et al. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001;44:1268-73.
30. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al.; for the Spanish Sleep and Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012;307:2161-8.
31. Mazzatti D, Lim FL, O'Hara A, Wood IS, Trayhurn P. A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. Arch Physiol Biochem 2012;118:112-20.
32. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007;9:679-87.
33. Lamounier-Zepter V, Look C, Alvarez J, et al. Adipocyte fatty acidbinding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009;105:326-34.